4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-24-005017
Options or other derivatives
- Director acquired 20,594 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROOT JONATHAN D Director | 2024-06-10 | Grant or award · Stock Option (Right to Buy) | +20,594 | 20,594 | D: show line 1 in the form |
Loading xslF345X05/primarydocument.xml…